|
|
Previous Article | Table of Contents | Next Article 
The P2Y1 Receptor Is Necessary for Adenosine
5 -Diphosphate-Induced Platelet Aggregation
Béatrice Hechler,
Catherine Léon,
Catherine Vial,
Paul Vigne,
Christian Frelin,
Jean-Pierre Cazenave, and
Christian Gachet
From INSERM U.311, Etablissement de Transfusion Sanguine de
Strasbourg, Strasbourg, Cédex, France; and Institut
de Pharmacologie Moléculaire et Cellulaire, CNRS UPR 411, Valbonne, France.
The human P2Y1 receptor heterologously expressed in
Jurkat cells behaves as a specific adenosine 5 -diphosphate (ADP)
receptor at which purified adenosine triphosphate (ATP) is an
ineffective agonist, but competitively antagonizes the action of ADP.
This receptor is thus a good candidate to be the elusive platelet P2T receptor for ADP. In the present work, we examined the
effects on ADP-induced platelet responses of two selective and
competitive P2Y1 antagonists,
adenosine-2 -phosphate-5 -phosphate (A2P5P) and
adenosine-3 -phosphate-5 -phosphate (A3P5P). Results were compared with those for the native P2Y1 receptor expressed
on the B10 clone of rat brain capillary endothelial cells (BCEC) and
for the cloned human P2Y1 receptor expressed on Jurkat
cells. A2P5P and A3P5P inhibited ADP-induced platelet shape change and aggregation (pA2 = 5) and competitively antagonized
calcium movements in response to ADP in fura-2-loaded platelets, B10
cells, and P2Y1-Jurkat cells. In contrast, these compounds
had no effect on ADP-induced inhibition of adenylyl cyclase in
platelets or B10 cells, whereas known antagonists of platelet
activation by ADP such as Sp-ATP S were effective. These identical
signaling responses and pharmacologic properties suggest that platelets and BCEC share a common P2Y1 receptor involved in
ADP-induced aggregation and vasodilation, respectively. This
P2Y1 receptor coupled to the mobilization of intracellular
calcium stores was found to be necessary to trigger ADP-induced
platelet aggregation. The present results, together with data from the
literature, also point to the existence of another as yet unidentified
ADP receptor, coupled to adenylyl cyclase and responsible for
completion of the aggregation response. Thus, the term, P2T, should no
longer be used to designate a specific molecular entity.
Blood, Vol. 92 No. 1 (July 1), 1998:
pp. 152-159
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Offermanns
Activation of Platelet Function Through G Protein-Coupled Receptors
Circ. Res.,
December 8, 2006;
99(12):
1293 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ibanez, G. Vilahur, and J. J. Badimon
Pharmacology of thienopyridines: rationale for dual pathway inhibition
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_G):
G3 - G9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev,
October 1, 2005;
85(4):
1159 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tolhurst, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith
Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling
Blood,
September 1, 2005;
106(5):
1644 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Baurand, A. Eckly, B. Hechler, G. Kauffenstein, J.-L. Galzi, J.-P. Cazenave, C. Leon, and C. Gachet
Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties?
Mol. Pharmacol.,
March 1, 2005;
67(3):
721 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martinez-Pinna, I. S. Gurung, C. Vial, C. Leon, C. Gachet, R. J. Evans, and M. P. Mahaut-Smith
Direct Voltage Control of Signaling via P2Y1 and Other G{alpha}q-coupled Receptors
J. Biol. Chem.,
January 14, 2005;
280(2):
1490 - 1498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leon, M. Alex, A. Klocke, E. Morgenstern, C. Moosbauer, A. Eckly, M. Spannagl, C. Gachet, and B. Engelmann
Platelet ADP receptors contribute to the initiation of intravascular coagulation
Blood,
January 15, 2004;
103(2):
594 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Bodor, G. L. Waldo, S. B. Hooks, J. Corbitt, J. L. Boyer, and T. K. Harden
Purification and Functional Reconstitution of the Human P2Y12 Receptor
Mol. Pharmacol.,
November 1, 2003;
64(5):
1210 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fontana, A. Dupont, S. Gandrille, C. Bachelot-Loza, J.-L. Reny, M. Aiach, and P. Gaussem
Adenosine Diphosphate-Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects
Circulation,
August 26, 2003;
108(8):
989 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Patel, K. Patel, S. Rahman, M. P. Smith, G. Spooner, R. Sumathipala, M. Mitchell, G. Flynn, A. Aitken, and G. Savidge
Evidence for a role for G{alpha}i1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced G{alpha}i1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder
Blood,
June 15, 2003;
101(12):
4828 - 4835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nieswandt, V. Schulte, A. Zywietz, M.-P. Gratacap, and S. Offermanns
Costimulation of Gi- and G12/G13-mediated Signaling Pathways Induces Integrin alpha IIbbeta 3 Activation in Platelets
J. Biol. Chem.,
October 11, 2002;
277(42):
39493 - 39498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lova, S. Paganini, F. Sinigaglia, C. Balduini, and M. Torti
A Gi-dependent Pathway Is Required for Activation of the Small GTPase Rap1B in Human Platelets
J. Biol. Chem.,
March 29, 2002;
277(14):
12009 - 12015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jin, T. M. Quinton, J. Zhang, S. E. Rittenhouse, and S. P. Kunapuli
Adenosine diphosphate (ADP)-induced thromboxane A2 generation in human platelets requires coordinated signaling through integrin alpha IIbbeta 3 and ADP receptors
Blood,
January 1, 2002;
99(1):
193 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Turner, J. L. Moake, and L. V. McIntire
Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow
Blood,
December 1, 2001;
98(12):
3340 - 3345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hechler, P. Toselli, C. Ravanat, C. Gachet, and K. Ravid
Mpl Ligand Increases P2Y1 Receptor Gene Expression in Megakaryocytes with No Concomitant Change in Platelet Response to ADP
Mol. Pharmacol.,
November 1, 2001;
60(5):
1112 - 1120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Nicholas
Identification of the P2Y12 Receptor: A Novel Member of the P2Y Family of Receptors Activated by Extracellular Nucleotides
Mol. Pharmacol.,
September 1, 2001;
60(3):
416 - 420.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Takasaki, M. Kamohara, T. Saito, M. Matsumoto, S.-i. Matsumoto, T. Ohishi, T. Soga, H. Matsushime, and K. Furuichi
Molecular Cloning of the Platelet P2TAC ADP Receptor: Pharmacological Comparison with Another ADP Receptor, the P2Y1 Receptor
Mol. Pharmacol.,
September 1, 2001;
60(3):
432 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev,
April 1, 2001;
81(2):
767 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leon, M. Freund, C. Ravanat, A. Baurand, J.-P. Cazenave, and C. Gachet
Key Role of the P2Y1 Receptor in Tissue Factor-Induced Thrombin-Dependent Acute Thromboembolism : Studies in P2Y1-Knockout Mice and Mice Treated With a P2Y1 Antagonist
Circulation,
February 6, 2001;
103(5):
718 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
Eur. Heart J.,
December 2, 2000;
21(24):
2033 - 2041.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Gratacap, J.-P. Herault, C. Viala, A. Ragab, P. Savi, J.-M. Herbert, H. Chap, M. Plantavid, and B. Payrastre
Fcgamma RIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation
Blood,
November 15, 2000;
96(10):
3439 - 3446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cattaneo, A. Lecchi, R. Lombardi, C. Gachet, and M. L. Zighetti
Platelets From a Patient Heterozygous for the Defect of P2CYC Receptors for ADP Have a Secretion Defect Despite Normal Thromboxane A2 Production and Normal Granule Stores : Further Evidence That Some Cases of Platelet 'Primary Secretion Defect' Are Heterozygous for a Defect of P2CYC Receptors
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2000;
20
(11):
e101 - e106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ohlmann, A. Eckly, M. Freund, J.-P. Cazenave, S. Offermanns, and C. Gachet
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galpha q
Blood,
September 15, 2000;
96(6):
2134 - 2139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawashima, T. Nagasawa, and H. Ninomiya
Contribution of ecto-5'-nucleotidase to the inhibition of platelet aggregation by human endothelial cells
Blood,
September 15, 2000;
96(6):
2157 - 2162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. B. Francischetti, J. M. C. Ribeiro, D. Champagne, and J. Andersen
Purification, Cloning, Expression, and Mechanism of Action of a Novel Platelet Aggregation Inhibitor from the Salivary Gland of the Blood-sucking Bug, Rhodnius prolixus
J. Biol. Chem.,
April 21, 2000;
275(17):
12639 - 12650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Trumel, B. Payrastre, M. Plantavid, B. Hechler, C. Viala, P. Presek, E. A. Martinson, J.-P. Cazenave, H. Chap, and C. Gachet
A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase
Blood,
December 15, 1999;
94(12):
4156 - 4165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Quinn and D. J. Fitzgerald
Ticlopidine and Clopidogrel
Circulation,
October 12, 1999;
100(15):
1667 - 1672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cattaneo and C. Gachet
ADP Receptors and Clinical Bleeding Disorders
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1999;
19(10):
2281 - 2285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bauer, M. Retzer, J. I. Wilde, P. Maschberger, M. Essler, M. Aepfelbacher, S. P. Watson, and W. Siess
Dichotomous Regulation of Myosin Phosphorylation and Shape Change by Rho-Kinase and Calcium in Intact Human Platelets
Blood,
September 1, 1999;
94(5):
1665 - 1672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Geiger, J. Brich, P. Honig-Liedl, M. Eigenthaler, P. Schanzenbacher, J. M. Herbert, and U. Walter
Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel
Arterioscler. Thromb. Vasc. Biol.,
August 1, 1999;
19(8):
2007 - 2011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Yap, S. C. Hughan, S. L. Cranmer, W. S. Nesbitt, M. M. Rooney, S. Giuliano, S. Kulkarni, S. M. Dopheide, Y. Yuan, H. H. Salem, et al.
Synergistic Adhesive Interactions and Signaling Mechanisms Operating between Platelet Glycoprotein Ib/IX and Integrin alpha IIbbeta 3. STUDIES IN HUMAN PLATELETS AND TRANSFECTED CHINESE HAMSTER OVARY CELLS
J. Biol. Chem.,
December 22, 2000;
275(52):
41377 - 41388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Schwiebert, W. C. Rice, B. A. Kudlow, A. L. Taylor, and E. M. Schwiebert
Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells
Am J Physiol Cell Physiol,
February 1, 2002;
282(2):
C289 - C301.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |